Prot# EZN-2208-04: A Phase 2 Study of EZN-2208 (PEG-SN38) Administered With or Without Cetuximab in Patients with Metastatic Colorectal Carcinoma (mCRC)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/13/0910/13/18

Funding

  • Enzon, Inc. (EZN-2208-04)